Atlas Trials

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Clinical trial NCT00354913 · COMPLETED

Trial details

NCT number
NCT00354913
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GlioblastomaGliosarcoma
Start date
2005-05-01
Primary completion
2009-03-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.